Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine (DA) is an organic chemical belonging to the catecholamine and phenethylamine families. It functions primarily as a neurotransmitter in the brain but also acts as a hormone in peripheral tissues. Dopamine transmits signals between nerve cells, influencing numerous physiological processes including movement, motivation, reward, mood regulation, attention, learning, memory, sleep-wake cycles, and executive function. Imbalances or dysfunctions within dopaminergic systems are implicated in several conditions including Parkinson’s disease, Schizophrenia, Addiction/Substance Use Disorders, Depression, and ADHD.
Dopamine itself is not a drug but rather a neurotransmitter. Drugs that target the dopaminergic system can act as agonists (e.g., L-DOPA, dopamine receptor agonists) to increase dopamine signaling, or as antagonists (e.g., antipsychotics) to decrease dopamine signaling. Other drugs may affect dopamine reuptake (e.g., stimulants) or release.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine (DA).